BCL2 and neoplasm: We found that the tumor volume and quality of sh-LINC01087#1 group were markedly inhibited (Figure 6A, 6B), the miR-384 expression in tumor tissues increased markedly, while the Bcl-2 expression was obviously inhibited (Figure 6C).